VasoSeal ES Website Understates Complication Rate, FDA Warning Says
This article was originally published in The Gray Sheet
Executive Summary
Datascope's website for its VasoSeal ES vascular hemostasis device indicates a lower complication rate than approved labeling for the device, FDA maintains in a July 24 warning letter. "The actual major complication rates are substantially higher than what is claimed," FDA says.